Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Adicionar filtros








Intervalo de ano
1.
Southeast Asian J Trop Med Public Health ; 1996 Mar; 27(1): 85-90
Artigo em Inglês | IMSEAR | ID: sea-31522

RESUMO

We performed a clinico-pathological study to determine which pre-treatment factors could predict the response to interferon (IFN) therapy in 55 Japanese patients with chronic hepatitis C. Responses to the IFN therapy were evaluated as sustained response, relapse and non-response by the presence or absence of serum hepatitis C virus (HCV) RNA during the course of treatment and at least 6-months post-treatment. The numbers of sustained response, relapse and non-response were 16 (29.0%), 25 (45.5%) and 14 (25.5%), respectively. Eight out of 16 sustained response cases (50%) showed HCV genotype III. Eight among 10 patients with HCV genotype III (80%) were sustained responders. HCV genotypes were found to be correlated with the response to the IFN therapy (p < 0.0001). None of the histological features, the types of the IFN therapy and other clinical factors showed significant differences. These findings suggest that outcome of the IFN therapy in chronic hepatitis C can be predicted by a virological factor, and that HCV genotype III is a useful predictor of a favorable outcome.


Assuntos
Biópsia , Relação Dose-Resposta a Droga , Esquema de Medicação , Seguimentos , Genótipo , Vírus da Hepatite B/genética , Hepatite C/patologia , Hepatite Crônica/patologia , Humanos , Injeções Subcutâneas , Interferon alfa-2/uso terapêutico , Interferon-alfa/uso terapêutico , Interferon-alfa/uso terapêutico , Japão , Fígado/patologia , Testes de Função Hepática , RNA Viral/sangue
2.
Southeast Asian J Trop Med Public Health ; 1994 Mar; 25(1): 88-92
Artigo em Inglês | IMSEAR | ID: sea-30978

RESUMO

Hepatocellular carcinoma (HCC) is one of the most prevalent cancers in Japan as well as Southeast Asia and Africa. On 89 patients with HCC in the Nagasaki City area were performed serological examinations and histopathological studies. The number of HBsAg positive and anti-HCV positive was three (3%), HBsAg positive and anti-HCV negative 21 (24%), HBsAg negative and anti-HCV positive 58 (65%) and HBsAg negative and anti-HCV negative seven (8%). These results strongly suggest that HCV infection is a more important factor in the development of HCC than HBV infection. The HBsAg negative and anti-HCV positive group showed a higher mean age and a higher male to female ratio than the HBsAg positive and anti-HCV negative group. Histological examinations showed no differences between these two groups. In addition, all cases were complicated with chronic hepatitis (CH) or liver cirrhosis (LC) in adjacent liver tissue. These findings suggest that CH and LC seem to play an important role in the pathogenesis of HCC.


Assuntos
Idoso , Idoso de 80 Anos ou mais , Carcinoma Hepatocelular/epidemiologia , Feminino , Anticorpos Anti-Hepatite/sangue , Hepatite B/sangue , Antígenos de Superfície da Hepatite B/sangue , Hepatite C/sangue , Anticorpos Anti-Hepatite C , Humanos , Japão/epidemiologia , Neoplasias Hepáticas/epidemiologia , Masculino , Pessoa de Meia-Idade , Estadiamento de Neoplasias , Vigilância da População , Fatores de Risco , Estudos Soroepidemiológicos , População Urbana
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA